Sort
39,280 grants matching “leukemia”
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
$410,606Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2016 · CA
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
$410,606Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Role of viral and cellular proteins in retroviral DNA integration
$410,547Robert Craigie · Diabetes, Digestive, Kidney Diseases · Z01 · FY2007 · DK
Natural product-derived differentiation agents for AML
$410,512Mukesh Kumar Agarwal · Invenio Therapeutics, Inc. · R44 · FY2012 · CA
The mechanisms of action of T-lymphocytes in neuropathic pain
$410,504Michael Costigan · Boston Children'S Hospital · R01 · FY2012 · NS
Advancing biological and clinical applications of genomic Minimal Residual Disease detection in AML
$410,483Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Natural Products Synthesis via Cycloaddition Reactions
$410,435William R Roush · Scripps Florida · R01 · FY2009 · GM
Natural Products Synthesis via Cycloaddition Reactions
$410,435William R Roush · Scripps Florida · R01 · FY2008 · GM
Hematopoietic regulation through Ott1-dependent alternative splicing
$410,375Glen D Raffel · Univ Of Massachusetts Med Sch Worcester · R01 · FY2014 · HL
E2A as a Tumor Suppressor
$410,326Cornelis Murre · University Of California, San Diego · R01 · FY2010 · CA
MOLECULAR BIOLOGY OF HUMAN MYELOID DIFFERENTIATION
$410,322Beth Israel Deaconess Medical Center · R01 · FY2003 · CA
Toxicity Monitoring on Phase III Trials with Administrative Data
$410,314Richard Aplenc · Children'S Hosp Of Philadelphia · R01 · FY2015 · CA
HSC Diversity, in aging, ontogeny, and transformation
$410,288Irving Lerner Weissman · Stanford University · R01 · FY2017 · CA
Sequestration and deactivation of anthracycline by adipocytes in the leukemia microenvironment
$410,198Steven David Mittelman · University Of California Los Angeles · R01 · FY2021 · CA
Characterizing stem cell-like B cell subpopulations and dissecting their role in tumorigenesis
$410,185Effie Apostolou · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Spatiotemporal Dynamics of Transcription and Splicing by Two Photon 3D Orbital Tracking
$410,174Matthew Lee Ferguson · Boise State University · R15 · FY2017 · GM
Rac proteins in hematopoietic cell survival and function
$410,128David A Williams · Boston Children'S Hospital · R01 · FY2016 · DK
Research in the Pathogenesis of Hematologic Disorders
$410,101Lawrence Benjamin Gardner · New York University School Of Medicine · T32 · FY2014 · HL
Eltrombopag for bone marrow failure
$410,089Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Macaque and human models for preclinical development of iPSCs
$410,089Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2019 · HL
Effector T-cell trafficking in graft-versus-host disease
$410,019Ran Reshef · Columbia University Health Sciences · R01 · FY2020 · HL
Experimental Therapeutics
$410,006Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2013 · CA
Regulation of Monocyte and Granulocyte Lineage Specification
$410,000Alan D Friedman · Johns Hopkins University · R01 · FY2009 · HL
Regulation of Monocyte and Granulocyte Lineage Specification
$410,000Alan D Friedman · Johns Hopkins University · R01 · FY2011 · HL
The Role of Pacs1-Wdr37 inLymphocyte Quiescence and Survival
$410,000Evan Nair-Gill · Ut Southwestern Medical Center · R01 · FY2024 · AI